Stopping Your GLP-1? Here’s the Exercise Math You Need Now

Sometimes the end of a journey is really just the beginning. If you have reached your desired weight goal and decided to stop your use of GLP-1s, you are feeling proud of yourself and you deserve to feel that way. You’ve done well.

But thinking this is the end is a mistake, and there is plenty of data to prove it.

The research is conclusive on this. Approximately 60% of adults who start a GLP-1 receptor agonist stop within a year. Most regain at least two-thirds of the weight they lost within the next 12 months along with most of the cardiometabolic benefits they earned getting there.

That’s not a willpower problem. It’s a biology problem. And the only intervention with real evidence behind it is one most patients are not ready to commit to.

Two pieces of news up front:

1. Good news: the research is clear that exercise can preserve weight loss after a GLP-1. There is a way to maintain without the drug.
2. Bad news: it takes substantially more exercise than your doctor recommended, your fitness tracker celebrates, or your friends on social media are doing.

This piece walks through the math. By the end, you should be able to answer one question honestly: Are you ready to exercise 5+ hours a week (roughly 45 minutes a day) for the foreseeable future? Because if the answer is “No,” the data says don’t stop the medication.

The Calorie Math, Done Honestly

The standard public health recommendation is 150 minutes per week of moderate-intensity exercise. That’s about 30 minutes a day for five days a week. Brisk walking. Doctor-approved. The bare minimum.

Here’s the part most patients don’t know: That 150-minute number was never designed for weight loss maintenance. It’s the recommendation from the CDC and the American Heart Association for cardiovascular health, metabolic health, and lower all-cause mortality. Those are huge benefits. They’re just not the same benefit. The CDC isn’t trying to help you keep weight off of a GLP-1. They’re trying to help you not die young. 

Here’s what 150 minutes a week actually buys you, in calories: 70 to 120 calories per day.

That’s it. Depending on your body weight and walking speed, the standard public health prescription burns somewhere between 70 and 120 calories per day. The number is small enough that almost anything you eat erases it. A medium-sized banana. A handful of almonds. Two Oreos. A tablespoon of peanut butter. A splash of half-and-half in your morning coffee.

Your daily exercise routine can be undone by a snack.

Meanwhile, the medication you’re stopping was eliminating roughly 780 calories a day. That’s a meal. A real one. Gone.

For an average eater on a 2,000-calorie diet, the high end of that range is about 780 fewer calories per day. The medication is doing more than 10 times the work that the standard exercise recommendation does. And it’s doing it on autopilot.

And the Math Gets Worse

Here’s what almost nobody tells patients before they stop.

Exercise isn’t just less efficient than the medication you’re stopping. It also triggers three biological responses that further shrink its benefit:

1. You move less the rest of the day. Patients who add an exercise routine tend to unconsciously reduce the rest of their movement. They park closer. They take the elevator. They sit longer in the evening because “I already worked out.” The technical term is compensatory reduction in non-exercise activity. The plain English version: Your body subtracts movement from the rest of the day to balance what you added.

2. Exercise increases hunger. Especially aerobic exercise at meaningful intensities. The very thing you’re doing to manage weight makes you hungrier at exactly the moment your GLP-1 is no longer keeping your appetite quiet.

3. People reward themselves. I earned this cookie. The psychology is universal. Most patients who add exercise to their routine compensate at the table.

Stack those three on top of the calorie math, and the standard exercise prescription doesn’t just fall short. It can come close to zero.

What the Research Says It Takes

Here’s the part of the conversation that often gets overlooked in most clinics.

Multiple studies and meta-analyses converge on a real number for what it takes to prevent weight regain after weight loss.

Minimum: 300 minutes (5 hours) a week of moderate activity. Roughly 45 minutes every day. Brisk walking counts. Sitting on the recumbent bike at 4 mph and scrolling your phone does not count.

Elevated target for patients with previous obesity: Multiple prospective studies of women who lost weight after obesity have found that 60 to 80 minutes a day of moderate activity provides strong protection against regain. That’s 7-to-9 hours a week.

Intensity can substitute for time, but only partially. If your activity is vigorous, the requirement drops to roughly 35 minutes a day. The reason the recommended range looks wide (45-to-80 minutes of moderate, or 35 of vigorous) isn’t a margin of error. It’s the intensity tradeoff: you can do less of it harder, or more of it easier. The total work has to land in the same neighborhood.

The honest takeaway: 5 hours a week is the absolute floor. Sixty-plus minutes a day is the standard for patients with previous obesity. GLP-1 patients are squarely in the second group.

Most patients are not ready for that. That’s not a judgment.The same body of research that establishes the threshold also establishes that unsupervised exercise prescriptions hit 10-29% adherence by 6-to-12 months. The thing that prevents regain is also the thing most patients don’t sustain.

But Do You Have to Exercise on a GLP-1?

You came here hoping someone in a white coat would tell you that the medication does all the work, that exercise doesn’t really matter, and that you can keep losing weight without ever stepping into a gym.

Honest answer: You can lose weight on a GLP-1 without exercising at all. The clinical data is clear on that. The medication does the calorie work. Multiple trials have shown 14-20% body weight loss in patients whose exercise was, charitably, walking from the parking lot to the office.

That’s the part most “Do I need to exercise on Ozempic?” articles won’t tell you. The medication is that effective at reducing intake.

But the math doesn’t end there. Here’s what you trade by skipping the exercise piece:

You lose more muscle than you should. Any rapid weight loss by any method, from intensive dieting to bariatric surgery to GLP-1 medication, burns through fat-free mass alongside the fat. Research suggests that 25 to 39% of weight lost during rapid weight loss is fat-free mass, mostly muscle (Lieberman, JAMA 2026). Newer industry-presented data is more favorable: At the 2026 European Congress on Obesity, Novo Nordisk reported that roughly 84% of weight loss on semaglutide came from fat mass, with muscle function reportedly preserved. The picture may be improving as the science matures, but the underlying principle holds: Resistance training is the only intervention that meaningfully protects what’s left.

Your metabolism drops further than necessary. Less muscle means lower resting metabolic rate. Less resting metabolic rate means the day you stop, taper, or hit a plateau, you’re starting from a worse baseline than the patient who lifted twice a week.

So no, you don’t have to exercise on a GLP-1, but you should know what you’re giving up if you don’t.

The honest version of the conversation: The medication is doing the calorie work. Exercise is doing the muscle, metabolism, and future-proofing work. One drug doesn’t replace the other.

What keeps the weight off?

If you’ve decided to stop, or you’re being forced off the medication by supply issues or cost, here’s what the evidence supports:

Resistance training, two days a week minimum. This is the most important intervention nobody prescribes. Resistance training preserves the muscle that any rapid weight loss method — GLP-1s included — burns through alongside the fat. Less muscle = lower metabolism = faster regain. Resistance training is the lever that protects your results from the inside.

Protein, every meal. 1.2 to 1.6 grams per kilogram of body weight per day is the consensus target for GLP-1 patients. That’s roughly 80 to 120 grams a day for most adults — and most patients are under that.

Hydration. GLP-1s slow gastric emptying, which means you’ve been getting less water from food than you realize. When the appetite returns, the dehydration habit often persists.

Learn how to track your protein and water properly.

Sleep. Sleep deprivation drives both regain and inflammation.

The 8× Difference Nobody Talks About

A 2025 study published in Obesity Medicine tracked patients on GLP-1 therapy and looked at one specific variable: who their prescriber was. The finding was stark.

Patients treated by an obesity specialist were 8 times more likely to persist on GLP-1 therapy than patients treated in general care settings.

The most common reasons patients stop GLP-1 therapy:

Every one of those is something an experienced obesity medicine practice is built to handle. Side effects get managed at the next weekly visit. Shortages get navigated by a practice with multiple pharmacy relationships. Cost gets restructured. The reason persistence is 8 times higher with an obesity specialist isn’t mysterious. It’s that the practice is structured for the actual cadence of GLP-1 care — not for a 15-minute visit once a year. Source: Liu S, et al. Obesity Medicine, 2025.

How We Think About This at Rivas

Rivas has been treating obesity as a chronic disease for more than 34 years. The single most consistent observation across that history is that the patients who keep weight off are the ones who never approached treatment as a sprint.

When a patient comes in talking about stopping a GLP-1, we don’t argue against it. We walk through the same math you just read. We ask three questions:

1. Why do you want to stop? Cost, side effects, the burden of weekly injections, you reached your goal — every answer changes the recommendation.
2. Have you built the exercise infrastructure that maintenance requires? Not “do you exercise sometimes.” Forty-three to 80 minutes a day, sustained, with resistance training. Most people haven’t. That’s not a failure; it’s a signal.
3. What does your support system look like for the next year? Maintenance is harder than the loss phase. The patients who hold it are usually the ones who don’t try to do it alone.

Sometimes the right answer is to stay on the medication at a maintenance dose. Sometimes it’s to taper down with structured support. The wrong answer is to stop without a plan.

Related Links:

• Unsure about your dosage? Check out our GLP-1 dose calculator
• Have you hit a Wegovy or Ozempic plateau? Here’s what’s happening
• Reached your goal on Wegovy? Here’s what maintenance looks like

FAQs

Citations

1. Lieberman DE, Aslan DH, Heymsfield SB. The conundrum of exercise for weight management in the GLP-1 receptor agonist era. JAMA. 2026.
2. Khan SS, Ndumele CE, Kazi DS. Discontinuation of glucagon-like peptide-1 receptor agonists. JAMA. 2025.
3. Liu S, et al. Factors contributing to non-persistence of glucagon-like peptide-1 agonists: a cross-sectional study. Obesity Medicine. 2025.
4. Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. NEJM. 2021. (The 4-arm trial)
5. Jensen SBK, Sandsdal RM, Janus C, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. eClinicalMedicine. 2024. (Post-treatment follow-up to Lundgren — strongest evidence on regain after stopping)
6. Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021.
7. Jakicic JM, et al. Physical activity and excess body weight and adiposity for adults: American College of Sports Medicine consensus statement. Med Sci Sports Exerc. 2024.
8. Lee IM, Djoussé L, Sesso HD, Wang L, Buring JE. Physical activity and weight gain prevention. JAMA. 2010.
9. Schoeller DA, Shay K, Kushner RF. How much physical activity is needed to minimize weight gain in previously obese women? Am J Clin Nutr. 1997.
10. Novo Nordisk body composition data on semaglutide 2.4 mg and 7.2 mg. Presented at the European Congress on Obesity (ECO), 2026.